| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |